Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Science9 min read

Tirzepatide vs Semaglutide (2026): Which GLP-1 Is More Effective?

Tirzepatide vs semaglutide - comparing the two leading GLP-1 medications for weight loss. Clinical results, side effects, dosing, cost, and how to choose.

Updated September 15, 2026

Medically reviewed on

How we review

How They Work Differently

Two unbranded GLP-1 injection pens side by side on a marble counter, one blue and one teal, compared next to a bowl of berries and a glass of water

Semaglutide targets a single receptor: GLP-1. Tirzepatide targets two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).

This dual-agonist mechanism is what sets tirzepatide apart. By activating both pathways simultaneously, tirzepatide provides enhanced appetite suppression, improved insulin sensitivity, and potentially greater metabolic benefits.

For a deeper dive into these mechanisms, see our article on how GLP-1 medications work. Think of semaglutide as a focused tool and tirzepatide as a broader one - both are effective, but they take different approaches.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

Clinical Trial Results

The SURMOUNT trials for tirzepatide showed average weight loss of up to 22.5% of body weight at the highest dose over 72 weeks. The STEP trials for semaglutide (Wegovy) showed average weight loss of about 15% over 68 weeks.

While these numbers come from different trials and direct comparison requires caution, the trend is clear: tirzepatide has consistently shown greater weight loss in clinical research. Both medications significantly outperform older weight loss drugs and lifestyle intervention alone.

Side Effect Profiles

Both medications share similar gastrointestinal side effects - nausea, vomiting, diarrhea, and constipation are common, especially during dose escalation. In clinical trials, tirzepatide's side effect rates were broadly comparable to semaglutide's, with some studies suggesting slightly higher rates of certain GI symptoms at the highest tirzepatide doses.

The overall tolerability of both medications is considered acceptable, and side effects typically decrease over time. Read our semaglutide side effects guide for detailed management strategies that apply to both medications.

Cost and Availability

Brand-name versions of both medications are expensive - typically over $1,000 per month at retail price. Semaglutide has been available longer and has more compounded options through telehealth providers, which can significantly reduce cost.

Compounded tirzepatide is increasingly available but still less widespread. Insurance coverage varies for both and is often limited for weight loss indications.

For a complete pricing breakdown, see our medication cost guide.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Dosing Comparison

Semaglutide (Wegovy) titrates from 0.25 mg to a maximum of 2.4 mg weekly over about 16 weeks. Tirzepatide (Mounjaro/Zepbound) starts at 2.5 mg and can go up to 15 mg weekly.

Both use gradual dose escalation to minimize side effects. The wider dosing range of tirzepatide gives providers more flexibility in finding the optimal dose.

For details on what the first month looks like, see our first month guide.

Can You Switch From Semaglutide to Tirzepatide?

Yes - switching from semaglutide to tirzepatide is common, especially for patients who plateau on semaglutide and want stronger results. Your provider will determine an appropriate starting dose of tirzepatide based on your current semaglutide dose and response. The reverse switch (tirzepatide to semaglutide) also happens, typically for cost reasons since compounded semaglutide is more widely available and less expensive.

Where to Get Either Medication Online

Both medications are available through licensed telehealth providers. Many providers offer both semaglutide and tirzepatide, while some specialize in one. Compare semaglutide providers or tirzepatide providers on our platform. For step-by-step instructions, see our guide on getting GLP-1 medications online.

Which One Is Right for You?

There's no universal answer. Tirzepatide may produce greater weight loss on average, which could be important for patients with more significant weight loss goals.

Semaglutide has a longer track record, more real-world data, and broader availability through telehealth providers. Some patients start with semaglutide and transition to tirzepatide if they hit a plateau, while others begin with tirzepatide based on their provider's recommendation.

The best choice depends on your health profile, weight loss goals, budget, and provider availability. Take our quiz to find a provider that offers the medication best suited to your needs.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)